Terms ending in 2031
Every in-force patent on AbbVie Inc.'s record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,266,950 | Isolation and Purification of Anti-IL-13 Antibodies Using Protein A Affinity Chromatography In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 8,426,408 | Pyrimidine Inhibitors of Kinases In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US D747,091 | Template for a Prescription Medicine Container In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 8,962,629 | Novel Tricyclic Compounds In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US D776,423 | Carrying Case for Medical Delivery Device In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US D747,602 | Template for a Prescription Medicine Container In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 8,546,405 | Anti-Viral Compounds In force · Medium confidence | AbbVie Inc. | In force | Medium confidence | |
| US D777,247 | Interface Portion of a Cassette In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 8,143,284 | Poly(ADP-RIBOSE)polymerase Inhibitors In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US D777,831 | Cassette In force · High confidence | AbbVie Inc. | In force | High confidence | |
| 71 more term ends in 2031 · Pro | |||||
10 of 81 patents shown. Soonest term end first, then patent number.
Pro members see all 81.
78 of these are in force and held by AbbVie Inc..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.